Clinical trials
Disease clinical trials
Below are recruiting disease clinical trials, each written for real people, not researchers. We’re tracking 9,359 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07567599Enrolling by invitation
Deep Brain Stimulation Surgery for Parkinson's Disease
This study follows people with Parkinson's disease who are having a surgical procedure called deep brain stimulation (DBS), where thin electrodes are placed in the brain to help control movement symptoms. Researchers will track how well the surgery works and how it affects daily activities.
Belo Horizonte, Minas GeraisAges Any age - NCT07567664Enrolling by invitation
Brain Changes in Neurodegenerative Diseases: A Tracking Study
This research study tracks how brain damage progresses in rare neurodegenerative diseases like frontotemporal dementia, primary progressive aphasia, PSP, CBS, and ALS. Researchers use brain imaging and tests to understand how these diseases spread in the brain, which could help develop better treatments.
Milan, LombardyAges 20–85 - NCT07563582Recruiting
Iron Supplement for Children with Celiac Disease and Low Iron
This study tests whether a special iron supplement taken by mouth helps children who have celiac disease (a condition where the body can't digest gluten) and low iron levels or anemia (not enough healthy red blood cells). The iron supplement is designed to be easily absorbed by the body.
Genova, ItalyAges 8–18 - NCT06528964Recruiting
Skin protein study for Alzheimer's, Parkinson's, and related disorders
This study looks at the skin of people with memory or movement disorders (like Alzheimer's, Parkinson's, ALS) to find proteins that may help diagnose these conditions. If you have one of these diseases or are a healthy older adult, you may be able to join by giving a small skin sample.
San Luis Potosí CityAges 45 years+ - NCT06459011Recruiting
TAKINGCARE: Helping caregivers of lung disease patients
This study aims to understand the needs of people with long-term lung diseases and their caregivers. The goal is to find ways to better support both patients and the family members who help care for them.
AveiroAges 18 years+ - NCT06561555RecruitingPhase 2
Testing a new drug for advanced HER2-positive Paget's disease
This trial tests an investigational drug called Disitamab Vedotin for people with advanced Paget's disease that tests positive for HER2. It aims to see if the drug can shrink tumors or improve skin lesions.
Shanghai, Shanghai MunicipalityAges 18–75 - NCT05806346Recruiting
TXA dosing for heart surgery patients on bypass
This trial studies whether giving tranexamic acid (TXA) based on patient needs during heart surgery works better than a one-size-fits-all approach. It may help reduce bleeding during surgery, while monitoring for clotting-related side effects.
SeoulAges 19 years+ - NCT07551661Recruiting
Walking With Poles for Parkinson Disease
This study tests whether using walking poles during regular walks helps people with Parkinson disease improve their movement and balance. You'll walk independently on your own schedule while using special poles designed to support your gait.
Johnson City, TennesseeAges Any age - NCT07556185Recruiting
Testing a home heart health monitoring app for kids
This study tests whether young people with heart conditions can use a home monitoring app called Medly to track their symptoms and weight. The app may help doctors catch problems earlier and keep kids healthier at home.
Toronto, OntarioAges 8–18 - NCT07557706RecruitingPhase 1
Vagus Nerve Stimulation to Improve Heart Function in Parkinson's Disease
This study tests a non-invasive ear-based stimulation technique (taVNS) to help regulate heart function in people with Parkinson's disease. The goal is to see if this gentle stimulation can improve blood pressure and heart rate control.
Birmingham, AlabamaAges 18–80 - NCT07558616Recruiting
Brain Stimulation for Sleep Problems in Nerve Disorders
This study tests a non-invasive brain stimulation technique called Hi-tACS to improve sleep in people with specific nerve/immune diseases (like MS or NMOSD) or chronic insomnia who have not responded to sleep medications. The goal is to help you fall asleep and stay asleep, and feel less tired during the day.
Beijing, Beijing MunicipalityAges 18–65 - NCT07556718RecruitingPhase 2
Amitriptyline for IBS-like Symptoms in Stable Crohn's Disease
This study tests whether a medication called amitriptyline can help reduce belly pain and bowel problems in people whose Crohn's disease is well-controlled. Amitriptyline is an older antidepressant that may help with pain and bowel symptoms even when inflammation is quiet.
Ann Arbor, MichiganAges 18–65 - NCT07554469Recruiting
Study of Finerenone for Kidney Disease in Type 2 Diabetes
This observational study tracks how well finerenone (a kidney-protective medication) works in adults with type 2 diabetes and chronic kidney disease in Spain. Researchers will measure changes in kidney function and disease risk over time to better understand the medication's real-world benefits.
Many LocationsAges 18 years+ - NCT07551492RecruitingPhase 3
New medicine for people with heart and blood vessel disease
This study tests an investigational medicine called HRS9531 for people with atherosclerotic cardiovascular disease (a buildup of plaque in the arteries that can lead to heart attacks and strokes). The trial aims to see if the medicine helps reduce risks in this condition.
Beijing, Beijing MunicipalityAges 18 years+ - NCT05332756Recruiting
Long-term follow-up of moyamoya care and family health
This trial follows people with moyamoya disease who are treated with medication only, and it also looks at first-degree relatives. The goal is to understand long-term outcomes and whether careful conservative care is beneficial over time.
Beijing, Beijing MunicipalityAges 2–60 - NCT05516667Recruiting
Study of Alzheimer’s patients and their families
This study follows people with Alzheimer’s disease and family members over 2 years. It uses regular questionnaires and medical checkups to better understand needs and health changes for patients and caregivers.
France, MarseilleAges 18 years+ - NCT06742450Recruiting
Comparing two ways to stimulate the brain for Parkinson's
This trial compares two methods of deep brain stimulation (constant current vs constant voltage) for people with Parkinson's who already have the device placed but haven't turned it on yet. The goal is to see which method works better.
BeijingAges 18–75 - NCT07548632RecruitingPhase 2/Phase 3
Testing a new eye drop medicine for dry eye disease
This study tests whether licaminlimab, a new type of eye drop medicine, helps relieve dry eye disease. You'll use the study medicine for several weeks while doctors track how your symptoms and eye health improve.
Aliso Viejo, CaliforniaAges 18 years+ - NCT07543731Recruiting
Study of how patients stick with cholesterol-lowering injection medications
This study follows people who are starting one of three injectable cholesterol medications (inclisiran, evolocumab, or alirocumab) to see how well they stick with treatment over time. Understanding medication adherence helps doctors and patients find ways to improve long-term health outcomes.
BaselAges 18–99 - NCT06074614Recruiting
Breathing and brain control in Parkinson's disease
This study looks at how the brain controls breathing in people with Parkinson's disease compared to healthy volunteers. It may help us understand breathing problems that can occur in Parkinson's.
Nijmegen, GelderlandAges 18 years+ - NCT07543601Recruiting
Better COPD care for people evaluated for lung cancer
This trial tests whether people being checked for possible lung cancer can also get improved care for a breathing condition called COPD (chronic obstructive pulmonary disease). It focuses on patients whose lung function tests show airflow problems.
VejleAges 18 years+ - NCT07543094Enrolling by invitation
Brain Stimulation for Early Alzheimer's Memory and Thinking
This study tests whether a special type of brain stimulation called temporal interference stimulation can improve memory and thinking skills in people with early-stage Alzheimer's disease. The treatment uses electrical stimulation to target specific brain areas without surgery.
Shanghai, Shanghai MunicipalityAges 50–75 - NCT07545317Recruiting
IL-23 Inhibitors for Active Crohn's Disease
This study follows patients with moderate-to-severe Crohn's disease who are starting a newer type of biologic medication called IL-23 inhibitors (guselkumab or risankizumab). Researchers want to understand how well these drugs work in real-world clinical practice and compare their effectiveness to other treatments.
Guangzhou, GuangdongAges 18–75 - NCT07544394Recruiting
Understanding Fatigue in Sjögren's Syndrome
This study explores why people with Sjögren's syndrome experience fatigue and what factors predict it. Researchers will follow you for 3 months to better understand your fatigue patterns and potentially improve treatment.
KahramanmaraşAges 18 years+
Hear when a new Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for disease?
- Yes. Clin2 currently lists 9,359 recruiting disease studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a disease trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a disease trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.